This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Dhurandhar NV, Petersen KS, Webster C. Key causes and contributors of obesity: a perspective. Nurs Clin North Am. 2021;56:449–64.
Sharma AM, Padwal R. Obesity is a sign—over-eating is a symptom: an aetiological framework for the assessment and management of obesity. Obes Rev. 2010;11:362–70.
Sivasubramanian R, Malhotra S. Genetic contributors to obesity. Gastroenterol Clin North Am. 2023;52:323–32.
Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T, et al. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA. 1999;282:1568–75.
Paz-Filho G, Mastronardi CA, Licinio J. Leptin treatment: facts and expectations. Metabolism. 2015;64:146–56.
Markham A. Setmelanotide: first approval. Drugs. 2021;81:397–403.
van der Valk ES, van den Akker ELT, Savas M, Kleinendorst L, Visser JA, Van Haelst MM, et al. A comprehensive diagnostic approach to detect underlying causes of obesity in adults. Obes Rev. 2019;20:795–804.
Butler MG, Miller JL, Forster JL. Prader-Willi syndrome—clinical genetics, diagnosis and treatment approaches: an update. Curr Pediatr Rev. 2019;15:207–44.
Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. 2012;22:1200–35.
Ferriere A, Tabarin A. Cushing’s syndrome: treatment and new therapeutic approaches. Best Pr Res Clin Endocrinol Metab. 2020;34:101381.
Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, et al. Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab. 2003;88:5593–602.
Carneiro-Barrera A, Amaro-Gahete FJ, Guillen-Riquelme A, Jurado-Fasoli L, Saez-Roca G, Martin-Carrasco C, et al. Effect of an interdisciplinary weight loss and lifestyle intervention on obstructive sleep apnea severity: the INTERAPNEA randomized clinical trial. JAMA Netw Open. 2022;5:e228212.
Greer SM, Goldstein AN, Walker MP. The impact of sleep deprivation on food desire in the human brain. Nat Commun. 2013;4:2259.
Allison KC, Spaeth A, Hopkins CM. Sleep and eating disorders. Curr Psychiatry Rep. 2016;18:92.
Kumar RB, Aronne LJ. Iatrogenic obesity. Endocrinol Metab Clin North Am. 2020;49:265–73.
McIntyre RS, Filteau MJ, Martin L, Patry S, Carvalho A, Cha DS, et al. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord. 2014;156:1–7.
Schramm PJ, Poland RE, Rao U. Bupropion response on sleep quality in patients with depression: implications for increased cardiovascular disease risk. Eur Neuropsychopharmacol. 2014;24:207–14.
Muratore AF, Attia E. Psychopharmacologic management of eating disorders. Curr Psychiatry Rep. 2022;24:345–51.
Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98:4565–92.
Knight MG, Anekwe C, Washington K, Akam EY, Wang E, Stanford FC. Weight regulation in menopause. Menopause. 2021;28:960–5.
Kelly DM, Jones TH. Testosterone and obesity. Obes Rev. 2015;16:581–606.
Author information
Authors and Affiliations
Contributions
NVD and HB contributed to conceptualization. SR, OA, MH, FJ, GK, MZ, and ANN performed the review of literature and contributed to writing. All authors contributed to the manuscript revision, read, and approved the submitted version.
Corresponding authors
Ethics declarations
Competing interests
NVD has received investigator initiated grant and consultation from Novo Nordisk in the past for projects unconnected with this manuscript.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ranjbar, S., Akinsiku, O., Hefner, M. et al. Management of obesities with a cause specific approach. Int J Obes (2024). https://doi.org/10.1038/s41366-024-01539-x
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41366-024-01539-x